Kenneth W. Merrell
Papers
1
Total Citations
26
H-Index
1
About
Dr. Kenneth W. Merrell is a leading radiation oncologist whose research focuses on the application of advanced proton therapy techniques to improve outcomes for patients with gastrointestinal and hepatobiliary malignancies. His major contributions center on demonstrating the safety and efficacy of intensity modulated proton therapy (IMPT) for challenging cancers, particularly hepatocellular carcinoma (HCC). In his landmark 2021 study, "Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience," Dr. Merrell provided the first robust clinical evidence that IMPT can deliver curative-intent radiation with exceptional precision, minimizing toxicity to surrounding healthy liver tissue. This work, which has garnered 26 citations, has helped establish proton therapy as a viable, less invasive option for HCC patients who are not surgical candidates. Beyond this study, Dr. Merrell’s broader portfolio includes pioneering research on stereotactic body radiation therapy (SBRT) and adaptive radiotherapy, consistently pushing the boundaries of dose escalation while reducing side effects. His clinical expertise and scholarly output have made him a sought-after collaborator and a respected voice in the field, directly influencing treatment paradigms for liver and pancreatic cancers.
Research Focus
Key Achievements
Top Papers
- 1